Development of Heme Oxygenase Inhibitors for the Prevention of Severe Jaundice in Infants

This publication has 38 references indexed in Scilit:

• Studies with the haeme oxygenase inhibitor Sn-protoporphyrin in patients with primary biliary cirrhosis and idiopathic haemochromatosis.
  Gut, 1990
• Sn-protoporphyrin lowers serum bilirubin levels, decreases biliary bilirubin output, enhances biliary heme excretion and potently inhibits hepatic heme oxygenase activity in normal human subjects
  Hepatology, 1988
• Sn-protoporphyrin blocks the increase in serum bilirubin levels that develops postnatally in homozygous Gunn rats.
  The Journal of Experimental Medicine, 1988
• Tin-protoporphyrin inhibits heme oxygenase and prevents the decline in hepatic heme and cytochrome P-450 contents produced in nude mice by tumor transplantation
  Biochemical and Biophysical Research Communications, 1988
• Proof that Sn-protoporphyrin inhibits the enzymatic catabolism of heme in vivo. Suppression of 14CO generation from radiolabeled endogenous and exogenous heme sources.
  The Journal of Experimental Medicine, 1987
• Sn-protoporphyrin inhibition of fetal and neonatal brain heme oxygenase. Transplacental passage of the metalloporphyrin and prenatal suppression of hyperbilirubinemia in the newborn animal.
  Journal of Clinical Investigation, 1986
• Long-term administration of massive doses of Sn-protoporphyrin in anemic mutant mice (sphha/sphha).
  The Journal of Experimental Medicine, 1985
• Studies on the mechanism of Sn-protoporphyrin suppression of hyperbilirubinemia. Inhibition of heme oxidation and bilirubin production.
  Journal of Clinical Investigation, 1985
• Control of heme and cytochrome P-450 metabolism by inorganic metals, organometals and synthetic metalloporphyrins.
  Environmental Health Perspectives, 1984
• Suppression of hyperbilirubinemia in the rat neonate by chromium-protoporphyrin. Interactions of metalloporphyrins with microsomal heme oxygenase of human spleen.
  The Journal of Experimental Medicine, 1982